UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
about
Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater.Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACADetection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat ModelIdentification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant.Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.Metabolite identification of seven active components of Huan-Nao-Yi-Cong-Fang in rat plasma using high-performance liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry.The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activitiesAnalytical differentiation of quinolinyl- and isoquinolinyl-substituted 1-(5-fluoropentyl)-1H-indole-3-carboxylates: 5F-PB-22 and its ten isomers.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18.In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation.Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.Synthetic cannabimimetic agents metabolized by carboxylesterases.In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
P2860
Q30244453-C87C08D3-95F9-42AC-8C93-CB44666141C0Q34464722-7033B7F0-0FA9-4A63-94B5-BC6624CCD9E0Q34499961-A6F361FB-0FAD-4271-AB3F-8771A7185D36Q34501432-F4FEAA8F-E79D-4E42-BFDB-C49F2CBB993CQ34504512-E343CBDA-4B1A-4A98-94C4-455F226F24BEQ34508567-3B34C57D-1F93-4A4C-B4B8-28E019ECF8DDQ35681912-D8FD763B-D408-4678-962D-84B8DC39DB7CQ37146954-DADBCB80-C14A-41D3-8EE0-07E7E3F11EDAQ37560597-12A66C32-4230-4763-BA63-48B4CFF74813Q38411456-46DAA727-4A8E-481A-9991-35D7530D5EDAQ38611708-263458B3-5D9B-4BF6-9E5D-509F354EC25AQ38616637-628FDC01-2FBE-41AC-9E47-21A30C071970Q39343163-1C957815-E437-49D8-A275-269E6CA9BDEFQ48020201-919BED73-F32A-4195-8FAB-F044EA2BD02BQ48152955-27EDF244-F71D-4AB0-80D7-873DE0D8A949Q48220900-6DA057CA-C5E6-4BBC-87C0-FD756328A43FQ48298013-4383E9AA-DA5A-458C-B97E-DC0FC62E652CQ49227467-3B17C8F0-83A1-42D5-8B5B-C1AD9ECEA649Q49556857-035EAC0E-F313-401D-96DC-4F0E1B542C59Q50277873-0E57D122-16EF-44A0-B8BD-3738166AF7B4Q50616345-FD2F922E-CD9B-4199-AD0C-89E524167EB7Q53546061-F69B333D-67D5-42D2-8361-074B504A1B6A
P2860
UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@ast
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@en
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@nl
type
label
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@ast
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@en
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@nl
prefLabel
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@ast
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@en
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@nl
P2093
P2860
P356
P1476
UPLC/ESI-MS/MS-based determina ...... PVT, by human liver microsome.
@en
P2093
Jun Zhe Min
Kenichiro Todoroki
Koichi Inoue
Mayu Suzuki
Ruri Kikura-Hanajiri
Takahiro Takayama
Toshimasa Toyo'oka
Yukihiro Goda
P2860
P304
P356
10.1002/BMC.3155
P577
2014-06-01T00:00:00Z